nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RARA—amyotrophic lateral sclerosis	0.716	1	CbGaD
Acitretin—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.00694	0.0498	CcSEcCtD
Acitretin—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.00599	0.0431	CcSEcCtD
Acitretin—White blood cell count increased—Riluzole—amyotrophic lateral sclerosis	0.00599	0.0431	CcSEcCtD
Acitretin—RBP1—tongue—amyotrophic lateral sclerosis	0.00503	0.117	CbGeAlD
Acitretin—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0311	CcSEcCtD
Acitretin—CYP26A1—embryo—amyotrophic lateral sclerosis	0.00404	0.0936	CbGeAlD
Acitretin—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0279	CcSEcCtD
Acitretin—RARG—tongue—amyotrophic lateral sclerosis	0.0038	0.088	CbGeAlD
Acitretin—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0232	CcSEcCtD
Acitretin—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0203	CcSEcCtD
Acitretin—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0203	CcSEcCtD
Acitretin—Isotretinoin—RARA—amyotrophic lateral sclerosis	0.0027	0.418	CrCbGaD
Acitretin—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0184	CcSEcCtD
Acitretin—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0176	CcSEcCtD
Acitretin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0174	CcSEcCtD
Acitretin—RBP1—embryo—amyotrophic lateral sclerosis	0.00241	0.0559	CbGeAlD
Acitretin—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0158	CcSEcCtD
Acitretin—Alitretinoin—RARA—amyotrophic lateral sclerosis	0.0022	0.341	CrCbGaD
Acitretin—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0156	CcSEcCtD
Acitretin—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0152	CcSEcCtD
Acitretin—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0147	CcSEcCtD
Acitretin—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0141	CcSEcCtD
Acitretin—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0137	CcSEcCtD
Acitretin—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0135	CcSEcCtD
Acitretin—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0129	CcSEcCtD
Acitretin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0127	CcSEcCtD
Acitretin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0122	CcSEcCtD
Acitretin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00167	0.012	CcSEcCtD
Acitretin—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0116	CcSEcCtD
Acitretin—Tretinoin—RARA—amyotrophic lateral sclerosis	0.00155	0.24	CrCbGaD
Acitretin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0111	CcSEcCtD
Acitretin—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0107	CcSEcCtD
Acitretin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0107	CcSEcCtD
Acitretin—CYP26A1—brain—amyotrophic lateral sclerosis	0.00148	0.0344	CbGeAlD
Acitretin—RXRG—medulla oblongata—amyotrophic lateral sclerosis	0.00139	0.0323	CbGeAlD
Acitretin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00991	CcSEcCtD
Acitretin—RBP1—spinal cord—amyotrophic lateral sclerosis	0.00137	0.0319	CbGeAlD
Acitretin—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00957	CcSEcCtD
Acitretin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0095	CcSEcCtD
Acitretin—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00938	CcSEcCtD
Acitretin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00914	CcSEcCtD
Acitretin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00908	CcSEcCtD
Acitretin—RXRG—spinal cord—amyotrophic lateral sclerosis	0.00124	0.0288	CbGeAlD
Acitretin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00886	CcSEcCtD
Acitretin—RXRA—nervous system—amyotrophic lateral sclerosis	0.00119	0.0276	CbGeAlD
Acitretin—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00844	CcSEcCtD
Acitretin—RBP1—nervous system—amyotrophic lateral sclerosis	0.00116	0.0268	CbGeAlD
Acitretin—RXRA—central nervous system—amyotrophic lateral sclerosis	0.00115	0.0266	CbGeAlD
Acitretin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00825	CcSEcCtD
Acitretin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00811	CcSEcCtD
Acitretin—RBP1—central nervous system—amyotrophic lateral sclerosis	0.00111	0.0258	CbGeAlD
Acitretin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00794	CcSEcCtD
Acitretin—RBP1—cerebellum—amyotrophic lateral sclerosis	0.00109	0.0253	CbGeAlD
Acitretin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00758	CcSEcCtD
Acitretin—RXRG—nervous system—amyotrophic lateral sclerosis	0.00105	0.0243	CbGeAlD
Acitretin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00735	CcSEcCtD
Acitretin—RARB—cerebellum—amyotrophic lateral sclerosis	0.00101	0.0234	CbGeAlD
Acitretin—RXRG—central nervous system—amyotrophic lateral sclerosis	0.00101	0.0234	CbGeAlD
Acitretin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.001	0.00721	CcSEcCtD
Acitretin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.000999	0.00718	CcSEcCtD
Acitretin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.000994	0.00714	CcSEcCtD
Acitretin—RXRB—nervous system—amyotrophic lateral sclerosis	0.000985	0.0228	CbGeAlD
Acitretin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000976	0.00701	CcSEcCtD
Acitretin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000976	0.00701	CcSEcCtD
Acitretin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000972	0.00698	CcSEcCtD
Acitretin—RXRB—central nervous system—amyotrophic lateral sclerosis	0.000948	0.022	CbGeAlD
Acitretin—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000942	0.00677	CcSEcCtD
Acitretin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00668	CcSEcCtD
Acitretin—RXRB—cerebellum—amyotrophic lateral sclerosis	0.000927	0.0215	CbGeAlD
Acitretin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000925	0.00665	CcSEcCtD
Acitretin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000918	0.00659	CcSEcCtD
Acitretin—RXRA—brain—amyotrophic lateral sclerosis	0.000912	0.0211	CbGeAlD
Acitretin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00651	CcSEcCtD
Acitretin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000898	0.00646	CcSEcCtD
Acitretin—RBP1—brain—amyotrophic lateral sclerosis	0.000885	0.0205	CbGeAlD
Acitretin—RARG—nervous system—amyotrophic lateral sclerosis	0.000874	0.0203	CbGeAlD
Acitretin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000873	0.00627	CcSEcCtD
Acitretin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000873	0.00627	CcSEcCtD
Acitretin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000866	0.00622	CcSEcCtD
Acitretin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000859	0.00618	CcSEcCtD
Acitretin—RARG—central nervous system—amyotrophic lateral sclerosis	0.000842	0.0195	CbGeAlD
Acitretin—RARG—cerebellum—amyotrophic lateral sclerosis	0.000823	0.0191	CbGeAlD
Acitretin—RARA—nervous system—amyotrophic lateral sclerosis	0.000822	0.019	CbGeAlD
Acitretin—RARB—brain—amyotrophic lateral sclerosis	0.000819	0.019	CbGeAlD
Acitretin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000806	0.00579	CcSEcCtD
Acitretin—RXRG—brain—amyotrophic lateral sclerosis	0.000801	0.0186	CbGeAlD
Acitretin—RARA—central nervous system—amyotrophic lateral sclerosis	0.000791	0.0183	CbGeAlD
Acitretin—RARA—cerebellum—amyotrophic lateral sclerosis	0.000773	0.0179	CbGeAlD
Acitretin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00555	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00553	CcSEcCtD
Acitretin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00553	CcSEcCtD
Acitretin—RXRB—brain—amyotrophic lateral sclerosis	0.000753	0.0174	CbGeAlD
Acitretin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00532	CcSEcCtD
Acitretin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000717	0.00515	CcSEcCtD
Acitretin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000706	0.00507	CcSEcCtD
Acitretin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00499	CcSEcCtD
Acitretin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00495	CcSEcCtD
Acitretin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00493	CcSEcCtD
Acitretin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000683	0.00491	CcSEcCtD
Acitretin—Depression—Riluzole—amyotrophic lateral sclerosis	0.000671	0.00482	CcSEcCtD
Acitretin—RARG—brain—amyotrophic lateral sclerosis	0.000668	0.0155	CbGeAlD
Acitretin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00474	CcSEcCtD
Acitretin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000656	0.00471	CcSEcCtD
Acitretin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000656	0.00471	CcSEcCtD
Acitretin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000654	0.0047	CcSEcCtD
Acitretin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000642	0.00461	CcSEcCtD
Acitretin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00456	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000632	0.00667	CbGpPWpGaD
Acitretin—CYP26A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000631	0.00666	CbGpPWpGaD
Acitretin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000631	0.00454	CcSEcCtD
Acitretin—RXRG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000631	0.00665	CbGpPWpGaD
Acitretin—RARA—brain—amyotrophic lateral sclerosis	0.000628	0.0146	CbGeAlD
Acitretin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00436	CcSEcCtD
Acitretin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000606	0.00435	CcSEcCtD
Acitretin—RXRA—Organelle biogenesis and maintenance—GFM1—amyotrophic lateral sclerosis	0.000605	0.00638	CbGpPWpGaD
Acitretin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000604	0.00434	CcSEcCtD
Acitretin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000604	0.00434	CcSEcCtD
Acitretin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00432	CcSEcCtD
Acitretin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0006	0.00431	CcSEcCtD
Acitretin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000595	0.00428	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000578	0.0061	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000567	0.00598	CbGpPWpGaD
Acitretin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000565	0.00406	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000558	0.00588	CbGpPWpGaD
Acitretin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000548	0.00394	CcSEcCtD
Acitretin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00392	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000544	0.00573	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000544	0.00573	CbGpPWpGaD
Acitretin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00389	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000535	0.00564	CbGpPWpGaD
Acitretin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000534	0.00384	CcSEcCtD
Acitretin—Tension—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00371	CcSEcCtD
Acitretin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000515	0.0037	CcSEcCtD
Acitretin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00367	CcSEcCtD
Acitretin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000509	0.00365	CcSEcCtD
Acitretin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000506	0.00363	CcSEcCtD
Acitretin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000488	0.00351	CcSEcCtD
Acitretin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00345	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000479	0.00505	CbGpPWpGaD
Acitretin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000474	0.00341	CcSEcCtD
Acitretin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000459	0.0033	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000455	0.00479	CbGpPWpGaD
Acitretin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00322	CcSEcCtD
Acitretin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00322	CcSEcCtD
Acitretin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00322	CcSEcCtD
Acitretin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00321	CcSEcCtD
Acitretin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00318	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000438	0.00462	CbGpPWpGaD
Acitretin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000438	0.00315	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00043	0.00453	CbGpPWpGaD
Acitretin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000429	0.00308	CcSEcCtD
Acitretin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000426	0.00306	CcSEcCtD
Acitretin—RBP1—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.000421	0.00444	CbGpPWpGaD
Acitretin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000417	0.003	CcSEcCtD
Acitretin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000415	0.00298	CcSEcCtD
Acitretin—RXRB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000412	0.00435	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000412	0.00435	CbGpPWpGaD
Acitretin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00294	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00281	CcSEcCtD
Acitretin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000388	0.00279	CcSEcCtD
Acitretin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000385	0.00277	CcSEcCtD
Acitretin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00274	CcSEcCtD
Acitretin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00271	CcSEcCtD
Acitretin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000373	0.00268	CcSEcCtD
Acitretin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00266	CcSEcCtD
Acitretin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00037	0.00266	CcSEcCtD
Acitretin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00264	CcSEcCtD
Acitretin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00264	CcSEcCtD
Acitretin—ALB—brain—amyotrophic lateral sclerosis	0.000354	0.00821	CbGeAlD
Acitretin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00254	CcSEcCtD
Acitretin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000351	0.00252	CcSEcCtD
Acitretin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000341	0.00245	CcSEcCtD
Acitretin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00244	CcSEcCtD
Acitretin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00244	CcSEcCtD
Acitretin—RBP1—Disease—TPK1—amyotrophic lateral sclerosis	0.000317	0.00334	CbGpPWpGaD
Acitretin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00227	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000313	0.0033	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000309	0.00326	CbGpPWpGaD
Acitretin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00221	CcSEcCtD
Acitretin—RARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000304	0.00321	CbGpPWpGaD
Acitretin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00218	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000303	0.0032	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.0003	0.00316	CbGpPWpGaD
Acitretin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00211	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000291	0.00307	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000285	0.00301	CbGpPWpGaD
Acitretin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00204	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000283	0.00299	CbGpPWpGaD
Acitretin—CYP26A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000283	0.00298	CbGpPWpGaD
Acitretin—CYP26A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000279	0.00294	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000279	0.00294	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000278	0.00294	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000274	0.00289	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000273	0.00288	CbGpPWpGaD
Acitretin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000273	0.00196	CcSEcCtD
Acitretin—RXRA—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000271	0.00286	CbGpPWpGaD
Acitretin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000271	0.00194	CcSEcCtD
Acitretin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00027	0.00194	CcSEcCtD
Acitretin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00193	CcSEcCtD
Acitretin—RXRB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000262	0.00276	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000262	0.00276	CbGpPWpGaD
Acitretin—RARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000259	0.00273	CbGpPWpGaD
Acitretin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00183	CcSEcCtD
Acitretin—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.000255	0.00269	CbGpPWpGaD
Acitretin—RBP1—Disease—VTA1—amyotrophic lateral sclerosis	0.000254	0.00267	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000252	0.00265	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000237	0.0025	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000232	0.00245	CbGpPWpGaD
Acitretin—RARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000231	0.00243	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00023	0.00243	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000227	0.00239	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000226	0.00238	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000223	0.00235	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000223	0.00235	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000221	0.00233	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000221	0.00233	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000217	0.00228	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000217	0.00228	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000216	0.00228	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000215	0.00226	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000211	0.00223	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000211	0.00223	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.000208	0.00219	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000207	0.00218	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000198	0.00209	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000198	0.00209	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000198	0.00209	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000198	0.00209	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.000198	0.00209	CbGpPWpGaD
Acitretin—RBP1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000192	0.00203	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000187	0.00197	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000186	0.00196	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000185	0.00195	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000184	0.00194	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000184	0.00194	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000181	0.0019	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000178	0.00188	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000178	0.00188	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000177	0.00187	CbGpPWpGaD
Acitretin—RBP1—Disease—PLB1—amyotrophic lateral sclerosis	0.000174	0.00183	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000173	0.00183	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00017	0.00179	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000167	0.00176	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000165	0.00174	CbGpPWpGaD
Acitretin—RARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00016	0.00169	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000157	0.00166	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000157	0.00165	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000156	0.00165	CbGpPWpGaD
Acitretin—RBP1—Disease—VCP—amyotrophic lateral sclerosis	0.000155	0.00163	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000154	0.00162	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000153	0.00161	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000152	0.0016	CbGpPWpGaD
Acitretin—RARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000149	0.00157	CbGpPWpGaD
Acitretin—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000146	0.00154	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000146	0.00154	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000144	0.00152	CbGpPWpGaD
Acitretin—RARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000144	0.00152	CbGpPWpGaD
Acitretin—RARB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000143	0.00151	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000143	0.0015	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000138	0.00145	CbGpPWpGaD
Acitretin—RARA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000138	0.00145	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000136	0.00144	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000136	0.00143	CbGpPWpGaD
Acitretin—RARB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000133	0.00141	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000132	0.00139	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00013	0.00137	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00013	0.00137	CbGpPWpGaD
Acitretin—RARB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000129	0.00136	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000128	0.00135	CbGpPWpGaD
Acitretin—RARA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000128	0.00135	CbGpPWpGaD
Acitretin—RARA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000124	0.00131	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000124	0.00131	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000122	0.00128	CbGpPWpGaD
Acitretin—RARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000121	0.00128	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000121	0.00127	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00012	0.00126	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000119	0.00125	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000116	0.00122	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000116	0.00122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000114	0.00121	CbGpPWpGaD
Acitretin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000114	0.0012	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000113	0.00119	CbGpPWpGaD
Acitretin—RBP1—Disease—CST3—amyotrophic lateral sclerosis	0.000111	0.00117	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000111	0.00117	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00011	0.00116	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000109	0.00115	CbGpPWpGaD
Acitretin—RARB—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000109	0.00115	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000108	0.00114	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000106	0.00111	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000105	0.00111	CbGpPWpGaD
Acitretin—RXRA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000105	0.00111	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000104	0.0011	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000103	0.00109	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.0001	0.00105	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.89e-05	0.00104	CbGpPWpGaD
Acitretin—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	9.72e-05	0.00103	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.59e-05	0.00101	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	9.57e-05	0.00101	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	9.56e-05	0.00101	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.33e-05	0.000983	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	9.29e-05	0.000979	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.29e-05	0.000979	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.22e-05	0.000972	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	9.22e-05	0.000972	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	9.05e-05	0.000954	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.99e-05	0.000948	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.9e-05	0.000939	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.87e-05	0.000935	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	8.62e-05	0.000909	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.38e-05	0.000884	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	8.38e-05	0.000884	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	8.3e-05	0.000875	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.23e-05	0.000868	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	8.2e-05	0.000865	CbGpPWpGaD
Acitretin—RBP1—Disease—CASP9—amyotrophic lateral sclerosis	8.08e-05	0.000852	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TPK1—amyotrophic lateral sclerosis	8.04e-05	0.000848	CbGpPWpGaD
Acitretin—RXRA—Metabolism—VAPB—amyotrophic lateral sclerosis	8.04e-05	0.000848	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.88e-05	0.000831	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.56e-05	0.000797	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.53e-05	0.000794	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	7.52e-05	0.000793	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.5e-05	0.00079	CbGpPWpGaD
Acitretin—RXRA—Metabolism—VAPA—amyotrophic lateral sclerosis	7.35e-05	0.000775	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	7.17e-05	0.000756	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.13e-05	0.000752	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.13e-05	0.000752	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7e-05	0.000738	CbGpPWpGaD
Acitretin—RBP1—Disease—ERBB4—amyotrophic lateral sclerosis	6.92e-05	0.000729	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	6.85e-05	0.000723	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.84e-05	0.000721	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—FUS—amyotrophic lateral sclerosis	6.66e-05	0.000703	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.58e-05	0.000694	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	6.45e-05	0.00068	CbGpPWpGaD
Acitretin—RXRA—Metabolism—FIG4—amyotrophic lateral sclerosis	6.43e-05	0.000678	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	6.4e-05	0.000675	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.35e-05	0.00067	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.34e-05	0.000668	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	6.03e-05	0.000636	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.95e-05	0.000628	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.94e-05	0.000627	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.93e-05	0.000626	CbGpPWpGaD
Acitretin—RXRA—Metabolism—DAO—amyotrophic lateral sclerosis	5.81e-05	0.000613	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.71e-05	0.000602	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	5.7e-05	0.000601	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.66e-05	0.000597	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	5.52e-05	0.000582	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—RARA—amyotrophic lateral sclerosis	5.43e-05	0.000573	CbGpPWpGaD
Acitretin—RBP1—Disease—APOE—amyotrophic lateral sclerosis	5.35e-05	0.000564	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	5.25e-05	0.000554	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	5e-05	0.000527	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.84e-05	0.000511	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.83e-05	0.000509	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	4.75e-05	0.000501	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.64e-05	0.000489	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.55e-05	0.00048	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.51e-05	0.000476	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.44e-05	0.000468	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	4.42e-05	0.000466	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLB1—amyotrophic lateral sclerosis	4.41e-05	0.000464	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	4.28e-05	0.000451	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	4.24e-05	0.000447	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSR—amyotrophic lateral sclerosis	4.07e-05	0.000429	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.03e-05	0.000424	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	4.01e-05	0.000423	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.94e-05	0.000415	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.82e-05	0.000403	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.75e-05	0.000395	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.00039	CbGpPWpGaD
Acitretin—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	3.67e-05	0.000387	CbGpPWpGaD
Acitretin—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	3.67e-05	0.000387	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—amyotrophic lateral sclerosis	3.67e-05	0.000387	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.65e-05	0.000385	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	3.6e-05	0.00038	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	3.6e-05	0.000379	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	3.43e-05	0.000362	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.42e-05	0.000361	CbGpPWpGaD
Acitretin—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	3.35e-05	0.000354	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CHAT—amyotrophic lateral sclerosis	3.34e-05	0.000352	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.25e-05	0.000343	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.25e-05	0.000343	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	3.18e-05	0.000335	CbGpPWpGaD
Acitretin—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.12e-05	0.000329	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.1e-05	0.000327	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.05e-05	0.000321	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.98e-05	0.000314	CbGpPWpGaD
Acitretin—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	2.93e-05	0.000309	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.9e-05	0.000306	CbGpPWpGaD
Acitretin—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	2.65e-05	0.00028	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.5e-05	0.000264	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	2.45e-05	0.000258	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.38e-05	0.000251	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.25e-05	0.000237	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.09e-05	0.00022	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	2.07e-05	0.000218	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.05e-05	0.000216	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.02e-05	0.000213	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	2.01e-05	0.000212	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000196	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.85e-05	0.000196	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.84e-05	0.000194	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.79e-05	0.000189	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.69e-05	0.000178	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000174	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.6e-05	0.000169	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.53e-05	0.000161	CbGpPWpGaD
Acitretin—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.000161	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.39e-05	0.000147	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000143	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.26e-05	0.000133	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.52e-06	0.0001	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.3e-06	9.8e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	8.24e-06	8.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.18e-06	8.63e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.52e-06	7.93e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	6.22e-06	6.56e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	6.19e-06	6.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.24e-06	4.47e-05	CbGpPWpGaD
